FIELD: chemistry; pharmaceutics.
SUBSTANCE: present invention relates to use of dihydropyrazolone derivatives of formula (I), in which radicals and symbols are defined in p. 1 of patent claim.
EFFECT: making drug for treating and/or preventing cardiac diseases of blood circulation, cardiac failure, anemia, chronic diseases of kidneys and renal failure, as well as medicinal agent containing said dihydropyrazolone derivatives, and method of treating and/or preventing said diseases in human and animals.
4 cl, 10 tbl, 180 ex
Title | Year | Author | Number |
---|---|---|---|
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
HETEROCYCLYLAMIDOSUBSTITUTED IMIDAZOLE DERIVATIVES | 2006 |
|
RU2415851C2 |
NEW CYCLOPENTA[B]BENZOFURANYL DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2415847C9 |
ACYLATED NONA-DEPSIPEPTIDES AS LYSOBACTIN DERIVATIVES | 2005 |
|
RU2414477C2 |
REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
ERBB/BTK INHIBITORS | 2019 |
|
RU2764069C1 |
TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
ERBB RECEPTOR INHIBITORS | 2019 |
|
RU2810215C2 |
SELECTIVE KINASE JAK1 INHIBITOR | 2020 |
|
RU2818002C2 |
NEW 3-INDOLE SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION | 2016 |
|
RU2672252C1 |
Authors
Dates
2017-02-17—Published
2012-08-10—Filed